{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:15:16Z","timestamp":1792062916195,"version":"4.4.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T00:00:00Z","timestamp":1621209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T00:00:00Z","timestamp":1621209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s10787-021-00818-7","type":"journal-article","created":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T14:02:57Z","timestamp":1621260177000},"page":"1169-1185","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Dapagliflozin, an SGLT2 inhibitor, ameliorates acetic acid-induced colitis in rats by targeting NF\u03baB\/AMPK\/NLRP3 axis"],"prefix":"10.1007","volume":"29","author":[{"given":"Magdy Abou","family":"El-Rous","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5070-7851","authenticated-orcid":false,"given":"Sameh","family":"Saber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman M.","family":"Raafat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amany A. E.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,17]]},"reference":[{"key":"818_CR1","doi-asserted-by":"crossref","unstructured":"Bae HR et al. (2016) \u03b2-Hydroxybutyrate suppresses inflammasome formation by ameliorating endoplasmic reticulum stress via AMPK activation 7:66444","DOI":"10.18632\/oncotarget.12119"},{"key":"818_CR2","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1016\/j.bcp.2010.08.009","volume":"80","author":"A Bai","year":"2010","unstructured":"Bai A et al (2010) AMPK agonist downregulates innate and adaptive immune responses in TNBS-induced murine acute and relapsing colitis. Biochem Pharmacol 80:1708\u20131717","journal-title":"Biochem Pharmacol"},{"key":"818_CR3","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1053\/gast.2002.34752","volume":"123","author":"G Bouma","year":"2002","unstructured":"Bouma G, Kaushiva A, Strober W (2002) Experimental murine colitis is regulated by two genetic loci, including one on chromosome 11 that regulates IL-12 responses. Gastroenterology 123:554\u2013565. https:\/\/doi.org\/10.1053\/gast.2002.34752","journal-title":"Gastroenterology"},{"key":"818_CR4","doi-asserted-by":"crossref","unstructured":"Chang Y-K, Choi H, Jeong JY, Na K-R, Lee KW, Lim BJ, Choi DEJPo (2016) Dapagliflozin, SGLT2 inhibitor, attenuates renal ischemia-reperfusion injury 11","DOI":"10.1371\/journal.pone.0160478"},{"key":"818_CR5","doi-asserted-by":"crossref","unstructured":"Hawley SA et al. (2016) The Na+\/glucose cotransporter inhibitor canagliflozin activates AMPK by inhibiting mitochondrial function and increasing cellular AMP levels 65:2784\u20132794","DOI":"10.2337\/db16-0058"},{"key":"818_CR6","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1007\/s00125-019-4859-4","volume":"62","author":"HJL Heerspink","year":"2019","unstructured":"Heerspink HJL, Perco P, Mulder S, Leierer J, Hansen MK, Heinzel A, Mayer G (2019) Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease. Diabetologia 62:1154\u20131166. https:\/\/doi.org\/10.1007\/s00125-019-4859-4","journal-title":"Diabetologia"},{"key":"818_CR7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jep.2003.09.042","volume":"90","author":"A Jagtap","year":"2004","unstructured":"Jagtap A, Shirke S, Phadke A (2004) Effect of polyherbal formulation on experimental models of inflammatory bowel diseases. J Ethnopharmacol 90:195\u2013204","journal-title":"J Ethnopharmacol"},{"key":"818_CR8","doi-asserted-by":"publisher","first-page":"5581","DOI":"10.3748\/wjg.v13.i42.5581","volume":"13","author":"M Kawada","year":"2007","unstructured":"Kawada M, Arihiro A, Mizoguchi E (2007) Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease. World J Gastroenterol 13:5581\u20135593. https:\/\/doi.org\/10.3748\/wjg.v13.i42.5581","journal-title":"World J Gastroenterol"},{"key":"818_CR9","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ncb2152","volume":"13","author":"J Kim","year":"2011","unstructured":"Kim J, Kundu M, Viollet B, Guan K-L (2011) AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 13:132\u2013141. https:\/\/doi.org\/10.1038\/ncb2152","journal-title":"Nat Cell Biol"},{"key":"818_CR10","doi-asserted-by":"crossref","unstructured":"K\u0131ng\u0131r ZB et al. (2019) Effects of dapagliflozin in experimental sepsis model in rats 25:213\u2013221","DOI":"10.5505\/tjtes.2018.82826"},{"key":"818_CR11","doi-asserted-by":"crossref","unstructured":"Lamkanfi M, Walle LV, Kanneganti TDJIr (2011) Deregulated inflammasome signaling in disease 243:163\u2013173","DOI":"10.1111\/j.1600-065X.2011.01042.x"},{"key":"818_CR12","doi-asserted-by":"crossref","unstructured":"Latz E, Xiao TS, Stutz AJNRI (2013b) Activation and regulation of the inflammasomes 13:397-411","DOI":"10.1038\/nri3452"},{"key":"818_CR13","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nri3452","volume":"13","author":"E Latz","year":"2013","unstructured":"Latz E, Xiao TS, Stutz A (2013a) Activation and regulation of the inflammasomes. Nat Rev Immunol 13:397\u2013411","journal-title":"Nat Rev Immunol"},{"key":"818_CR14","doi-asserted-by":"crossref","unstructured":"Leng W et al. (2016) The SGLT-2 inhibitor dapagliflozin has a therapeutic effect on atherosclerosis in diabetic ApoE\u2212\/\u2212 mice 2016","DOI":"10.1155\/2016\/6305735"},{"key":"818_CR15","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.3748\/wjg.v20.i13.3507","volume":"20","author":"G Maconi","year":"2014","unstructured":"Maconi G, Furfaro F, Sciurti R, Bezzio C, Ardizzone S, de Franchis R (2014) Glucose intolerance and diabetes mellitus in ulcerative colitis: pathogenetic and therapeutic implications. World J Gastroenterol WJG 20:3507","journal-title":"World J Gastroenterol WJG"},{"key":"818_CR16","doi-asserted-by":"crossref","unstructured":"Martinon F, Burns K, Tschopp JJMc (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-\u03b2 10:417\u2013426","DOI":"10.1016\/S1097-2765(02)00599-3"},{"key":"818_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.intimp.2016.04.043","volume":"38","author":"AH Palla","year":"2016","unstructured":"Palla AH, Iqbal NT, Minhas K, Gilani A-H (2016) Flaxseed extract exhibits mucosal protective effect in acetic acid induced colitis in mice by modulating cytokines, antioxidant and antiinflammatory mechanisms. Int Immunopharmacol 38:153\u2013166. https:\/\/doi.org\/10.1016\/j.intimp.2016.04.043","journal-title":"Int Immunopharmacol"},{"key":"818_CR18","doi-asserted-by":"publisher","first-page":"272","DOI":"10.2174\/1874467212666190308103448","volume":"12","author":"H Park","year":"2019","unstructured":"Park H, Kim W, Kim D, Jeong S, Jung Y (2019) Mesalazine activates adenosine monophosphate-activated protein kinase: implication in the anti-inflammatory activity of this anti-colitic drug current. Mol Pharmacol 12:272\u2013280","journal-title":"Mol Pharmacol"},{"key":"818_CR19","doi-asserted-by":"crossref","unstructured":"Perrotta C, Pellegrino P, Moroni E, De Palma C, Cervia D, Danelli P, Clementi E (2015) Five-aminosalicylic acid: an update for the reappraisal of an old drug Gastroenterology research and practice 2015","DOI":"10.1155\/2015\/456895"},{"key":"818_CR20","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.taap.2018.12.020","volume":"364","author":"S Saber","year":"2019","unstructured":"Saber S, Khalil RM, Abdo WS, Nassif D, El-Ahwany E (2019) Olmesartan ameliorates chemically-induced ulcerative colitis in rats via modulating NF\u03baB and Nrf-2\/HO-1 signaling crosstalk. Toxicol Appl Pharmacol 364:120\u2013132. https:\/\/doi.org\/10.1016\/j.taap.2018.12.020","journal-title":"Toxicol Appl Pharmacol"},{"key":"818_CR21","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.abb.2019.07.014","volume":"671","author":"S Saber","year":"2019","unstructured":"Saber S, Basuony M, Eldin AS (2019a) Telmisartan ameliorates dextran sodium sulfate-induced colitis in rats by modulating NF-\u03baB signalling in the context of PPAR\u03b3 agonistic activity. Arch Biochem Biophys 671:185\u2013195. https:\/\/doi.org\/10.1016\/j.abb.2019.07.014","journal-title":"Arch Biochem Biophys"},{"key":"818_CR22","doi-asserted-by":"publisher","first-page":"115075","DOI":"10.1016\/j.taap.2020.115075","volume":"400","author":"S Saber","year":"2020","unstructured":"Saber S et al (2020a) Celastrol augments sensitivity of NLRP3 to CP-456773 by modulating HSP-90 and inducing autophagy in dextran sodium sulphate-induced colitis in rats. Toxicol Appl Pharmacol 400:115075. https:\/\/doi.org\/10.1016\/j.taap.2020.115075","journal-title":"Toxicol Appl Pharmacol"},{"key":"818_CR23","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00280-020-04033-z","volume":"85","author":"S Saber","year":"2020","unstructured":"Saber S, Ghanim AMH, El-Ahwany E, El-Kader EMA (2020b) Novel complementary antitumour effects of celastrol and metformin by targeting I\u03baB\u03baB, apoptosis and NLRP3 inflammasome activation in diethylnitrosamine-induced murine hepatocarcinogenesis. Cancer Chemother Pharmacol 85:331\u2013343. https:\/\/doi.org\/10.1007\/s00280-020-04033-z","journal-title":"Cancer Chemother Pharmacol"},{"key":"818_CR24","doi-asserted-by":"publisher","first-page":"119123","DOI":"10.1016\/j.lfs.2021.119123","volume":"270","author":"S Saber","year":"2021","unstructured":"Saber S et al (2021) BBG enhances OLT1177-induced NLRP3 inflammasome inactivation by targeting P2X7R\/NLRP3 and MyD88\/NF-\u03baB signaling in DSS-induced colitis in rats. Life Sci 270:119123. https:\/\/doi.org\/10.1016\/j.lfs.2021.119123","journal-title":"Life Sci"},{"key":"818_CR25","doi-asserted-by":"crossref","unstructured":"Schroder K, Tschopp JJc (2010) The inflammasomes 140:821\u2013832","DOI":"10.1016\/j.cell.2010.01.040"},{"key":"818_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142203","author":"OR Shamaa","year":"2015","unstructured":"Shamaa OR, Mitra S, Gavrilin MA, Wewers MD (2015) Monocyte caspase-1 is released in a stable, active high molecular weight complex distinct from the unstable cell lysate-activated caspase-1. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0142203","journal-title":"PLoS ONE"},{"key":"818_CR27","doi-asserted-by":"publisher","first-page":"11934","DOI":"10.1038\/s41598-019-48331-w","volume":"9","author":"M Takahara","year":"2019","unstructured":"Takahara M et al (2019) Berberine improved experimental chronic colitis by regulating interferon-\u03b3- and IL-17A-producing lamina propria CD4+ T cells through AMPK activation. Sci Rep 9:11934. https:\/\/doi.org\/10.1038\/s41598-019-48331-w","journal-title":"Sci Rep"},{"key":"818_CR28","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1126\/science.aar3318","volume":"359","author":"CA Thaiss","year":"2018","unstructured":"Thaiss CA et al (2018) Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection. Science 359:1376\u20131383","journal-title":"Science"},{"key":"818_CR29","doi-asserted-by":"crossref","unstructured":"Uthman L et al. (2019) Empagliflozin and dapagliflozin reduce ROS generation and restore NO bioavailability in tumor necrosis factor \u03b1-stimulated human coronary arterial endothelial cells 53:865\u2013886","DOI":"10.33594\/000000178"},{"key":"818_CR30","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1007\/s00125-018-4670-7","volume":"61","author":"S Verma","year":"2018","unstructured":"Verma S, McMurray JJV (2018) SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review. Diabetologia 61:2108\u20132117. https:\/\/doi.org\/10.1007\/s00125-018-4670-7","journal-title":"Diabetologia"},{"key":"818_CR31","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1161\/CIRCRESAHA.109.212530","volume":"106","author":"S Wang","year":"2010","unstructured":"Wang S et al (2010) AMPK\u03b12 deletion causes aberrant expression and activation of NAD (P) H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes. Circ Res 106:1117","journal-title":"Circ Res"},{"key":"818_CR32","doi-asserted-by":"publisher","unstructured":"Washburn WN (2014) Chapter twenty-three-case history: forxigaTM (Dapagliflozin), a potent selective SGLT2 inhibitor for treatment of diabetes. In: Desai MC (ed) Annual reports in medicinal chemistry, vol 49. Academic Press, pp 363\u2013382. https:\/\/doi.org\/10.1016\/B978-0-12-800167-7.00023-7","DOI":"10.1016\/B978-0-12-800167-7.00023-7"},{"key":"818_CR33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.biopha.2017.06.071","volume":"94","author":"W Wei","year":"2017","unstructured":"Wei W, Ding M, Zhou K, Xie H, Zhang M, Zhang C (2017) Protective effects of wedelolactone on dextran sodium sulfate induced murine colitis partly through inhibiting the NLRP3 inflammasome activation via AMPK signaling. Biomed Pharmacother 94:27\u201336","journal-title":"Biomed Pharmacother"},{"key":"818_CR34","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1177\/1756283x11405250","volume":"4","author":"C Williams","year":"2011","unstructured":"Williams C, Panaccione R, Ghosh S, Rioux K (2011) Optimizing clinical use of mesalazine (5-aminosalicylic acid) in inflammatory bowel disease. Ther Adv Gastroenterol 4:237\u2013248. https:\/\/doi.org\/10.1177\/1756283x11405250","journal-title":"Ther Adv Gastroenterol"},{"key":"818_CR35","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.yexmp.2016.03.003","volume":"100","author":"Y Xiong","year":"2016","unstructured":"Xiong Y, Lou Y, Su H, Fu Y, Kong J (2016) Cholecalciterol cholesterol emulsion ameliorates experimental colitis via down-regulating the pyroptosis signaling pathway. Exp Mol Pathol 100:386\u2013392","journal-title":"Exp Mol Pathol"},{"key":"818_CR36","doi-asserted-by":"publisher","first-page":"109526","DOI":"10.1016\/j.biopha.2019.109526","volume":"120","author":"H Yaribeygi","year":"2019","unstructured":"Yaribeygi H, Simental-Mend\u00eda LE, Banach M, Bo S, Sahebkar AJB (2019) The major molecular mechanisms mediating the renoprotective effects of SGLT2 inhibitors: an update. Biomed Pharmacother 120:109526","journal-title":"Biomed Pharmacother"},{"key":"818_CR37","doi-asserted-by":"crossref","unstructured":"Ye Y, Bajaj M, Yang H-C, Perez-Polo JR, Birnbaum YJCd, therapy (2017) SGLT-2 inhibition with dapagliflozin reduces the activation of the Nlrp3\/ASC inflammasome and attenuates the development of diabetic cardiomyopathy in mice with type 2 diabetes. Further augmentation of the effects with saxagliptin, a DPP4 inhibitor 31:119\u2013132","DOI":"10.1007\/s10557-017-6725-2"},{"key":"818_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00276","author":"Y Zhen","year":"2019","unstructured":"Zhen Y, Zhang H (2019) NLRP3 inflammasome and inflammatory bowel disease. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2019.00276","journal-title":"Front Immunol"},{"key":"818_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21688370.2018.1487249","volume":"6","author":"M-J Zhu","year":"2018","unstructured":"Zhu M-J, Sun X, Du M (2018) AMPK in regulation of apical junctions and barrier function of intestinal epithelium. Tissue Barr 6:1\u201313. https:\/\/doi.org\/10.1080\/21688370.2018.1487249","journal-title":"Tissue Barr"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-021-00818-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-021-00818-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-021-00818-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T05:28:34Z","timestamp":1626931714000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-021-00818-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,17]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["818"],"URL":"https:\/\/doi.org\/10.1007\/s10787-021-00818-7","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,17]]},"assertion":[{"value":"1 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}